Dr. Jong-Yoon Chun, the CEO of Seegene Institue of Life Science, announced its entry into co-marketing agreement with VWR international in USA. VWR intends to focus not only on biotechnological instruments, but also on chemicals. The agreement allows Seegene to enter US market.
?